Redeye embraces the initiation of IRRAS’ clinical study ACTIVE as Aarhus University Hospital in Denmark begins its commercial use of IRRAflow. The study aims to compare IRRAflow treatment to traditional passive drainage, and we expect additional danish centres to follow. We are pleased to see the company advancing with its clinical programs, which we argue are of utmost importance for broad commercial success. Adding additional centres should positively impact its sales in the shorter term, too, we judge.